Aptose Biosciences Inc. (APTO)

Number of records: 34
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
06-Jun-22 4:13 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 06-Jun-22Private Purchase 10,000$0.97$9,681.003%
343.25K to 353.25K
21-Dec-21 11:19 AM
View: 
Burger Denis R
Director
Aptose Biosciences Inc. (APTO) 20-Dec-21Market Purchase 10,000$1.45$14,490.0046%
21.67K to 31.67K
(4%)
17-Dec-21 1:38 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 16-Dec-21Market Purchase 13,183$1.52$20,038.204%
330.07K to 343.25K
(3%)
20-Dec-21 4:33 PM
View: 
Platzer Erich
Director
Aptose Biosciences Inc. (APTO) 16-Dec-21Market Purchase 100,000$1.38$137,900.0025%
405.0K to 505.0K
9%
15-Dec-21 1:48 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 15-Dec-21Market Purchase 17,822$1.12$19,960.606%
312.25K to 330.07K
(< 1%)
17-Dec-21 1:45 PM
View: 
Platzer Erich
Director
Aptose Biosciences Inc. (APTO) 15-Dec-21Market Purchase 270,000$1.17$316,340.00200%
135.0K to 405.0K
25%
29-Nov-21 11:53 AM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 26-Nov-21Market Purchase 8,643$2.31$19,965.303%
303.6K to 312.25K
(1%)
19-Nov-21 8:36 PM
View: 
Bejar Rafael
Sr. VP, Chief Medical Officer
Aptose Biosciences Inc. (APTO) 19-Nov-21Market Purchase 10,000$2.56$25,600.00100%
0 to 10.0K
(4%)
19-Nov-21 8:42 PM
View: 
Burger Denis R
Director
Aptose Biosciences Inc. (APTO) 19-Nov-21Option Exercise 5,417$2.04$11,050.7033%
16.25K to 21.67K
06-Jul-21 5:07 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 02-Jul-21Market Purchase 6,081$3.29$19,998.002%
297.52K to 303.6K
2%
23-Jun-21 5:08 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 22-Jun-21Market Sale 9,600$3.24$31,104.00(39%)
24.6K to 15.0K
(2%)
23-Jun-21 5:08 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 21-Jun-21Market Sale 15,400$3.35$51,590.00(38%)
40.0K to 24.6K
1%
28-Dec-20 6:00 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 22-Dec-20Option Exercise 20,000$2.01$40,200.0050%
40.0K to 60.0K
28-Dec-20 6:00 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 22-Dec-20Market Option Sale 20,000$4.06$81,200.00(33%)
60.0K to 40.0K
10-Jul-20 6:57 PM
View: 
Chow Gregory K.
Executive VP & CFO
Aptose Biosciences Inc. (APTO) 10-Jul-20Market Sale 126,668$6.05$766,341.00(35%)
359.51K to 232.85K
30%
10-Jul-20 6:55 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 10-Jul-20Market Sale 168,891$6.05$1,021,790.00(36%)
466.41K to 297.52K
30%
10-Jul-20 6:53 PM
View: 
Marango Jotin
Senior VP, Chief Bus. Officer
Aptose Biosciences Inc. (APTO) 10-Jul-20Market Sale 62,835$6.05$380,152.00(35%)
179.05K to 116.22K
30%
02-Jul-20 8:08 PM
View: 
Marango Jotin
Senior VP, Chief Bus. Officer
Aptose Biosciences Inc. (APTO) 02-Jul-20Market Sale 20,946$6.34$132,793.00(10%)
200.0K to 179.05K
33%
25-Jun-20 6:38 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 24-Jun-20Option Exercise 12,000$1.94$23,300.0027%
45.0K to 57.0K
25-Jun-20 6:38 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 24-Jun-20Market Sale 10,000$6.74$67,447.10(20%)
50.0K to 40.0K
37%
25-Jun-20 6:38 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 24-Jun-20Market Option Sale 7,000$6.74$47,212.90(12%)
57.0K to 50.0K
37%
25-Jun-20 6:38 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 23-Jun-20Market Option Sale 18,000$7.11$127,890.00(29%)
63.0K to 45.0K
40%
25-Jun-20 6:38 PM
View: 
Whitehead Warren
Director
Aptose Biosciences Inc. (APTO) 23-Jun-20Option Exercise 13,000$1.51$19,662.5026%
50.0K to 63.0K
26-Mar-20 1:10 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 25-Mar-20Market Purchase 3,400$5.82$19,803.00< 1%
463.01K to 466.41K
(27%)
12-Mar-20 4:33 PM
View: 
Marango Jotin
Senior VP, Chief Bus. Officer
Aptose Biosciences Inc. (APTO) 10-Mar-20Grant 120,000----150%
80.0K to 200.0K
12-Mar-20 4:21 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 10-Mar-20Grant 300,000----184%
163.01K to 463.01K
12-Mar-20 4:37 PM
View: 
Chow Gregory K.
Executive VP & CFO
Aptose Biosciences Inc. (APTO) 10-Mar-20Grant 225,000----167%
134.51K to 359.51K
28-Oct-19 1:59 PM
View: 
Rice William G.
Chairman, President & CEO
Director
Aptose Biosciences Inc. (APTO) 24-Oct-19Market Purchase 10,000$1.92$19,200.007%
153.01K to 163.01K
123%
07-Jun-19 2:03 PM
View: 
Chow Gregory K.
Senior VP & CFO
Aptose Biosciences Inc. (APTO) 05-Jun-19Market Purchase 7,500$1.84$13,815.006%
127.01K to 134.51K
133%
05-Jun-19 1:21 PM
View: 
Marango Jotin
Senior VP, Chief Bus. Officer
Aptose Biosciences Inc. (APTO) 03-Jun-19Grant 80,000----100%
0 to 80.0K
19-Apr-19 2:35 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 18-Apr-19Market Purchase 10,000$1.85$18,507.007%
143.01K to 153.01K
132%
20-Mar-19 2:19 PM
View: 
Platzer Erich
Director
Aptose Biosciences Inc. (APTO) 19-Mar-19Market Sale 20,000$2.19$43,805.0017%
115.0K to 135.0K
96%
15-Mar-19 4:35 PM
View: 
Rice William G.
Chair, President & CEO
Director
Aptose Biosciences Inc. (APTO) 14-Mar-19Market Purchase 10,000$1.90$18,993.008%
133.01K to 143.01K
126%
14-Mar-19 5:32 PM
View: 
Chow Gregory K.
Senior VP & CFO
Aptose Biosciences Inc. (APTO) 13-Mar-19Market Purchase 15,000$1.75$26,322.0013%
112.01K to 127.01K
145%